XML 43 R32.htm IDEA: XBRL DOCUMENT v3.25.1
Segments (Tables)
3 Months Ended
Mar. 31, 2025
Segment Reporting [Abstract]  
Schedule of Financial Data for the Company’s Reportable Segment

The following table presents certain financial data for the Company’s reportable segment (in thousands):

 

Schedule of Financial Data for the Company’s Reportable Segment 

   2025   2024 
   March 31, 
   2025   2024 
Research & development expense – clinical asset development  $189   $128 
Research & development expense – related parties   1,120    - 
General and administrative expenses – legal & professional fees   760    245 
General and administrative expenses – accounting & audit fees   544    647 
General and administrative expenses – salaries, payroll and stock-based compensation   693    986 
General and administrative expenses – other   703    949 
Loss from segment operations  $4,009   $2,955